Celgene announces public offering of Senior Notes due 2019, 2024 and 2044 - Form 8-K


Wednesday, 7 May 2014 02:18pm EDT 

Celgene Corp:Announces underwritten public offering of $500 mln aggregate principal amount of 2.250pct Senior Notes due 2019, $1 bln aggregate principal amount of 3.625pct Senior Notes due 2024 and $1 bln aggregate principal amount of 4.625pct Senior Notes due 2044.Intends to use the net proceeds for general corporate purposes.Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse Securities (USA) LLC, Goldman, Sachs & Co. and Morgan Stanley & Co. LLC acts as underwriters. 

Company Quote

121.53
-1.82 -1.48%
27 Feb 2015